Levaquin Lawyers Claim Pharmaceutical Company Knew Of Drug Risks

April 10, 2017 – – Attorneys for plaintiffs claim that pharmaceutical company Johnson & Johnson knew of the risks associated with their drug, yet marketed and sold Levaquin anyway. Johnson & Johnson has been in and out of legal proceedings many times over the past two years, many of those cases related to their antibiotic called Levaquin.

“Claimants allege that the company not only knew of the risks associated with this drug, but that they failed to properly warn consumers that there was a risk at all,” says a spokesperson for Levaquin-lawsuit.org, which is a website devoted to providing information about the lawsuits and resources to consumers regarding filing claims.

Levaquin lawyers claim that Johnson & Johnson knew that the antibiotic, which is part of the fluoroquinolone class of drugs, could cause a painful nerve condition called peripheral neuropathy. They state that even though the company was aware of this danger, they aggressively marketed the medication.

“Thousands of lawsuits have been filed in state courts across the nation as more and more consumers come forward with lifelong injuries that they claim were caused by Levaquin,” says the representative for Levaquin-lawsuit.org. “The cases claim that Johnson & Johnson knew of these risks as early as 1996, yet did nothing to stop their medication from being sold to and used by consumers.”

Lawsuits claim that the company willingly committed fraud by failing to warn physicians and consumers about the risks of developing neuropathy, which has proven to be a permanent condition in many plaintiffs in these cases. Scientific data showed in the 1990’s that the medication could be considered high risk, yet the pharmaceutical company continued to market it as a remedy for minor infections.

The new label on the drug advises against using it for minor or uncomplicated infections like bronchitis and sinus infections. This same warning can now be seen on all fluoroquinolone class medications, including Avelox and Cipro, which are manufactured by Bayer Healthcare, a defendant in its own cases similar to those of Levaquin.

The pharmaceutical giant maintains that it handled the situations properly and says that they believe their actions have always been responsible and appropriate. Courts have disagreed, however, awarding plaintiffs in some cases millions of dollars.

###

Contact Drug-Lawsuits.org:

info@drug-lawsuits.org

ReleaseID: 60016937